Prognostic factors for multiple myeloma in the era of novel agents

Ann Oncol. 2008 Sep:19 Suppl 7:vii117-20. doi: 10.1093/annonc/mdn437.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Humans
  • Multiple Myeloma / diagnosis*
  • Multiple Myeloma / drug therapy
  • Multiple Myeloma / genetics
  • Multiple Myeloma / therapy*
  • Neoplasm Staging
  • Prognosis